India to United Kingdom: Apixaban Export Trade Route
India has recorded 113 verified shipments of Apixaban exported to United Kingdom, representing a combined trade value of $3.7M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $32.6K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 56% of total export value with 61 shipments worth $2.1M USD. On the buying side, Accord UK is the largest importer in United Kingdom with $990.0K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, TORRENT PHARMACEUTICALS LTD, UNISON PHARMACEUTICALS PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Apixaban corridor is one of India's established pharmaceutical export routes, with 113 shipments documented worth a combined $3.7M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $32.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with apixaban's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 22.9%, placing it at rank #4 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in United Kingdom include Accord UK, ACCORD UK, TORRENT PHARMA (UK) LIMITED and 15 others. Accord UK is the single largest importer with 32 shipments valued at $990.0K USD.
